Molecular cloning and functional expression of a recombinant 72.5 kDa fragment of the 110 kDa regulatory subunit of smooth muscle protein phosphatase 1M  by Haystead, Clare M.M. et al.
FFBS 16389 FEBS Letters 377 (1995) 123-127 
Molecular cloning and functional expression of a recombinant 72.5 kDa 
fragment of the 110 kDa regulatory subunit of smooth muscle protein 
phosphatase 1M 
Clare M.M. Haystead a, Philippe Gailly b, Andrew P. Somlyo b, Avril V. Somlyo b, 
Timothy A.J. Haystead a'* 
~Department of Pharmacology, Box 448, University of Virginia Health Sciences Center, Charlottesville, VA 22908. USA 
bDepartment of Molecular Physiology and Biophysics. University o1 Virginia, Charlottesville, VA 22908, USA 
Received 11 October 1995 
Abstract We have cloned a partial rat kidney cDNA that en- 
codes a 72.5 kDa N terminal fragment of a third isoform of the 
M l l0  subunit of phosphatase 1. This new isoform contains an 
inert in the 542-597 position not present in the M l l0  previously 
chined (Chen et al. (1994) FEBS Lett. 356, 51-55) from the same 
species. The encoded cDNA was expressed as a soluble GST- 
fusion protein in E. coli, and its ability to interact with native 
PP-1C was measured both in vitro and in permeabilized smooth 
muscle. In vitro, the fusion protein was capable of selectively 
binding PP-IC and increasing the substrate specificity of the 
phosphatase towards myosin 13.2 + 3.5-fold (S.E. of the mean, 
n = 3). In permeabilized smooth muscle pretreated with microcys- 
tin, the recombinant protein alone (1.0 btM) did not cause relax- 
ation, but did significantly enhance the ability of PP-1C (0.3 pM) 
to relax the muscle. These findings show that the N terminal 
domain of the M l l0  subunit is the primary site for both PP-1C 
and myosin binding, and thereby determines myosin specificity. 
The presence of isoformic variation within this sequence may 
permit organ/cell specific regulation of phosphorylation sites. 
K~ y words." Smooth muscle; Protein phosphatase; Myosin: 
cl ~NA sequence; Microcystin 
I. Introduction 
Phosphorylation of the myosin P light chain (MLC20) on 
se~'ine 19 is the key event that triggers contraction in smooth 
m lscle. Much has been learned about the regulation of the 
enzyme that catalyzes this reaction, the Ca2+/Calmodulin-sensi - 
tix e protein kinase, myosin light chain kinase (MLCK) (for 
reJiew see [1,2]). However, the mechanisms that regulate 
m .~osin light chain phosphatase activity and their physiological 
significance have only recently been recognized (for review see 
[3 4] and refs. therein). At least three laboratories have purified 
to homogeneity the major form of avian and mammalian 
smooth muscle myosin phosphatase, SMPP-1M [5-7]. By SDS- 
PAGE analysis, SMPP-1M consists of a heterotrimer of sub- 
m~its of 130 kDa, 37 kDa and 20 kDa respectively [5,6]. The 
3": kDa subunit has been identified by amino acid sequencing 
as the catalytic subunit of protein phosphatase 1 [5,6]. The 130 
*( orresponding author. 
A/,breviations: Smooth muscle protein phosphatase 1M, SMPP-IM; 
cmalytic subunit of protein phosphatase 1, PP-IC; 130 kDa myosin 
binding subunit, M 110; 20 kDa myosin binding subunit, M21; glutathi- 
one-S-transferase, GST; microcystin, MC. 
kDa and 20 kDa subunits can be separated from PP-1C using 
high concentrations of chaotropic agents. Once separated from 
these subunits, PP-IC dramatically oses specificity for myosin, 
regaining it when the subunits are remixed [5,6]. Since, the 130 
kDa and 20 kDa subunits can not be readily separated from 
each other under non-denaturing conditions, it is not clear 
whether both subunits are required for myosin and PP-1C 
binding or if they can act independently of one another. Indica- 
tion of the role of the 130 kDa subunit has come from data 
showing that a 58 kDa proteolytic fragment has both myosin 
and PP-1C binding properties in vitro [5,7]. In addition, digoxi- 
genin-labeled PP-1C was demonstrated to bind exclusively to 
the 130 kDa subunit in Western blotting studies [5]. 
The primary structures of rat aorta and chicken gizzard 
SMPP-1M 130 kDa [7,8] and 20 kDa [8] subunits have been 
determined by cDNA cloning. The full length nucleotide se- 
quences were obtained from partial overlapping cDNA's and 
predicted to encode proteins in both species with molecular 
masses of ~ 110 kDa (designated M 110 here on) for the 130 kDa 
subunit and 21 kDa (designated M21 here on) for the 20 kDa 
subunit. Alignment of the nucleotide sequence and encoded 
amino acid sequence shows that the chicken and rat M l l0 
subunits are highly conserved in their N-terminal regions. 
Greatest divergence between the two species occurs in the C 
terminal domain, which in the case of the rat M110 appears to 
contain the entire M21 chicken sequence. Chicken M21 was 
also isolated as a separate cDNA, leading to the suggestion that 
the rat M21 subunit may be derived from alternate splicing of 
the MI I0 [8]. 
In order to determine the functional role of the M 110 subunit 
and explore the existence of isoforms we have obtained in the 
current study a partial cDNA clone from a rat kidney cDNA 
library and show that it encodes a third isoform of M110. This 
new isoform contains an insert in the 542-597 position that is 
not present in the M110 previously cloned from the same spe- 
cies [8]. The clone was expressed as a 101 kDa soluble GST- 
fusion protein in E. coli. The ability of the recombinant M 
subunit o bind PP-1C and alter the substrate specificity of the 
phosphatase towards myosin was established both in vitro and 
in permeabilized smooth muscle. 
2. Materials and Methods 
2.1 Purification of Pig Bladder SMPP-1M 
SMPP-1M was purified from whole pig bladders using a modifica- 
tion of procedures described previously by Shirazi et al. [6]. Briefly, 
following the polyethylene glycol precipitation step, the pellet was re- 
suspended in buffer A (50 mM Tris-HCl pH 7.4 4°C, 100 mM NaCl, 
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1 mM EGTA, 1 mM EDTA, 0.03% Brij (w/v), 1 mM dithiothreitol, 
1 mM phenylmethylsulfonyl fluoride, 6 Hg/ml leupeptin, 1 mM Ben- 
zamidine), centrifuged at 100,000 × g for 30 min and applied directly 
to a 1.0 ml column of microcystin-Sepharose [9]. Following washing 
with buffer A plus 1 M salt, SMPP-1M was eluted with buffer A plus 
3 M sodium isothiocynate following methods previously described by 
Moorehead et al. [9]. The eluted protein was separated into its compo- 
nent subunits (37 kDa catalytic subunit and complex of 110 kDa and 
20 kDa M subunits) by applying the sodium isothiocynate luate di- 
rectly to an SW300 (Waters) gel filtration column equilibrated with 
buffer A plus 150 mM NaCI [6]. The purified catalytic subunit was 
dialyzed into buffer B [buffer A plus 50% glycerol] and stored at -20 ° C. 
To obtain amino acid sequence, the 110 kDa and 20 kDa subunit 
complex was dialyzed into 50 mM sodium bicarbonate pH 8.0 and 
digested for 18 hours with trypsin (1:50, w/w). Individual tryptic pep- 
tides were isolated by reverse phase HPLC and their amino acid se- 
quence determined in an Applied Biosystems gas phase sequencer. 
2.2. Molecular cloning and expression of rat kidney isoform of the 
110 kDa subunit of SMPP-1M 
To isolate cDNA clones encoding rat kidney SMPP1M 110 kDa 
subunit a rat cDNA 2gt 10 library was screened with two distinct 
oligonucleotide probes (5'GGAGTTGCAAAAAAAACAAAATCT- 
GCTCCATAGTGAAAAGCGGATAAGAAAY and 5'GAACCAG- 
AGAGAACAAGAAAACGAAGAAAAAGY) derived both from 
tryptic peptide fragments of pig bladder SMPP-1M, and previously 
published cDNA sequences of rat aorta [8] and chicken gizzard [7] 
MI10 subunits. Screening of 1 × 10 6 recombinants yielded 4 positive 
clones. A 2.0 kb clone was subcloned into the EcoRI site of pKS-, and 
sequence analysis was carried out on an Applied Biosystems 377 auto- 
mated DNA sequencer. Sequencing was performed at least twice in 
both directions. The cloned cDNA encoded an open reading frame of 
1975 bases corresponding to bp 153 (chicken)/bp 123 (rat aorta) and 
bp 2299 (chicken)/bp 2101 (rat aorta) in the previously published nucle- 
otide sequences of Chen et al. [8] and Shimizu et al. [7] (Fig.l). For 
expression as a recombinant protein, the partial cDNA clone was sub- 
cloned into the EcoRI site of the bacterial expression vector pGEX-4T 
and transformed into E. coli strain DH5a. Individual colonies were 
grown at 30°C in LB containing ampicillin (100,ug/ml) until an absorb- 
ance of 0.8 was reached at 600 nms. Isopropyl-fl-D-thiogalactopyra- 
noside (0.1 M final) was added to induce expression of the cloned 
subunit. After 16 hours, cells were harvested by centrifugation at 
6000 × g for 10 min. Following freezing at -20°C, the cells were thawed 
and lysed in 20 mls of buffer C (50 mM Tris-HCl pH 8.0, 150 mM NaCI, 
1 mM EGTA, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 6 
/lg/ml leupeptin, 1 mM benzamidine) containing 0.5 mg/ml lysozyme. 
Following complete lysis, NP40 (10/ll/litre) was added and the lysate 
centrifuged at 30,000 × g for 30 min. The supernatant was mixed with 
1.0 ml of a 1 : 1 slurry of GST-Sepharose (Pharmacia) for 30 minutes. 
The Sepharose was collected by mild centrifugation (500 × g for 2 rain), 
washed with buffer C plus 1 M NaCI, and the protein eluted with 4.0 
ml of C plus 5 mM glutathione. The protein was applied to an AP1Q 
(Waters) anion-exchange chromatography column (0.5 x 10 cm) equil- 
ibrated in buffer A. The column was developed (1.0 ml/min) with a 
linear salt gradient to 1 M NaCI in buffer A over 100 minutes. The 
purified fusion protein was identified in column fractions (1.0 ml) by 
SDS-PAGE and Coomassie blue staining, then dialyzed into buffer B 
and stored at -20°C. 
3. Results 
3.1. Nucleotide and predicted amino acid sequence 
Fig. 1 shows the nucleotide and corresponding predicted 
amino acid sequence of the cloned rat kidney M subunit cDNA.  
The cloned nucleotide sequence encodes a protein of  predicted 
molecular mass of 72557 Da. Amino acid alignment with the 
previously published rat aorta [8] and two chicken gizzard [7] 
M subunits shows that the clone is truncated at residue 658 in 
the C-terminal domain and lacks completely the M21 subunit 
sequence found in the M110 rat aorta sequence. In addition, 
at the N terminus, the clone lacks the initiating methionine and 
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CGCGAGCAGCTGAAGCGCTGGATCGGCTCCGAGACGGACCTCGAGCCTCC G GGTC, AAGCGCCAG 66 
E Q L K R W I G S E T D L E P P V V K R Q 22 
AAGACCAAGGTGAAGTTCGACGATGGC CCGTCT~ CTC GCCGC CTGC TC CAG CGGC GACACGGAC 132 
K T K V K F D D G A V F L A A C S S G D T D 44 
GAGGTCCTCAAGCTGCTGCACCGCGGCGCCGACATCAATTACGCCAATGTGGACGGACTCACCGCC 198 
E V L K L L H R G A D I N Y A N V D G L T A 66 
CTGCAC CAGG CTTGCATTGATGACAATGTTGATATG GTGAAG TTTC TGGTAGAAAATGGAGCAAAT 264 
L H Q A C I D D N V D M V K F L V E N G A N 88 
ATCAATCAAC CTGACAATGAAG C TG GATTC CAC TC CATGCA GCCG CTTC C TG T GGATATCTGGAT 330 
I hl Q P D N E G W I P L H A A A $ C G Y L D Ii0 
ATTGCAGAATTTTTGATTGGTCAAGGAGCACATGTAGGAGCTGTCAACAGTGAAGGTGACACAC CT 396 
I A E F L I G Q G A H V G A V N 6 E G D T P 132 
TTAGATATTG CAGAGGAGGAAGCAATGGAA G G C TAC'I~fCAAAA TGAG G TTAAT C G G CAAGG TGTT 462 
L D I A E E E A M E E L L Q N E V N R Q G V 154 
GATATA GAAG CAGC TCGA~GAAGAGGAAC G CA TAATGCTTAGAG AC G C GAGG CAGTGG TTGAAC 528 
D I E A A R K E E E R I M L R D A R Q W L N 176 
AGTGGTCACATCAGTGACGTCCGGCATGCAAAGTCCGGAGGCACAGCAC TCCACGTGGCAGCGGCC 594 
S G H I S D V R H A K $ G G T A L H V A A A 198 
A~GGGTATACAGAAGTTTTA~CTTTTAA TACAGGC AG GC TATG A T GTTAATATT~J%AGATTAT 660 
K G Y T E V L K L L I Q A G Y D V N I K D Y 220 
GATGGC TGGACA CC TC TTCATGCTG CAGC TCACTGGGG TAAAGAA GAAGCA TGTCGGATTTTAGTG 726 
D G W T P L H A A A H W G K E E A C R I L V 242 
GACAATCTGTGTGATATGGAGAC G GTCA AC AAAGTG GGCC AAAC AG C C T I~ATGTAGC AGATGAA 792 
D N L C D M E T V N K V G Q T A F D V A D E 264 
GA CATTTTGG GATATCTAGAGGAG TTG CAAAAAAAACAAAAT CT GC TC CATAGTGAAAAG CG GGAT 858 
D I L G Y L E E L Q K K Q N L L H S E K R D 286 
AAGAAATC TC C AC TGATTGAATCAAC AG CAAA TATG GAAAATAATC AA CCAC AGAAGAATTTTAAA 924 
K K S P L I E S T A N M E N N Q P Q K N F K 308 
~C~GG~CG~GA~A~AGCCAGAGAAAAATGCATCTCG~GAGTCTCTGGAGC~G~ 990 
N K E T L I I E P E K N A S R I E S L E Q E  318 
~GGCTGA~AGGAGGAGG~GGC~G~GGA~AGTCCAGCTGCTCCAG~AGGAGGATGAGGAG 1056 
K A D E E E E G K K D E S S C S S E E D E E  352 
~AC~CGAG~CG~GCGGAGACAGAT~GACAA~ACCCATGGCTTCTGT~CTAATGCTCAC 4122 
D D S E S E A E T D K T K P M A S V T N A H  374 
AC~CCAGCACTCAGGCA~CTGCCGC~TGAC~CACCTAC~TC~CC~CCAGGGGACC 1188 
T A S T Q A A P A A V T T P T L S S N Q G T  396 
CCTACA~ACCTGTTAAAAAGTTTCCTACA~CTACAAAAAT~CTCCCG~G~G~G~GA 1254 
P T S P V K K F P T S T T K I S P E E E E R  418 
~GATG~TCTCCTGCATCCTGGAGGTTAGGACTTAG~GACTGGCAG~ATGGTGCCCTGGCT 1320 
K D E S P A S W R L G L R K T G S Y G A L A  940 
GAGATCACTGCATCT~G~GCTCAG~GGAG~GACACTGCAGGCGTGATACG~CAGC~CG 1386 
E I T A S K E A Q K E K D T A G V I R S A S  462 
AG~CCAGACTCTCG~C~TG~T~T~G~GGAG~GAC~T~GG~C~GAC~ 1452 
S P R L S S S L D N K E K E K D N K G T R L  484 
GCATA~TCGCCCCTAC~TCCC~G~GACTAGGCAGTACG~ACAT~GAGAAGGA~C 1518 
A Y V A P T I P R R L G S T S D I E E K E N  506 
AGAGAG~C~PTTGCG~C~GTAG~ACAC~GA~GG~GA~ATCTT~ 1584 
R E S S N L R T S S S Y T R R K W E D D L K  528 
AAAAATAG~C~TC~TG~GGATCTAC~ACCATAG~GT~CTCCTT~GTAG~GAC~GAT 1650 
K N S S I N E G S T Y M R S C S F G R R Q D  550 
GA~ATTAGTTGTAGTGTTCC~GCACCACATC~CACC~CAG~ACCTCTCCAGCTGGGC~ 1716 
D L I S C S V P S T T S T P T V T S P A G L  572 
CAGAAAAGCT~CT~CCAGCAC~GCACTAC~C~CTCCCCCGGG~CCTCCCCAGCAGGC 1782 
Q K S F L S S T S T T A K T P P G S S P A G  594 
ACACAGAGCAGGTCATACCTCACTCC~AGGGATGAAGAG~TG~CCACAGG~GC~GA 1848 
T Q S R S Y L T P V R D E E S E S H R K A R  616 
~TAGAC~GC~GACAG~TAGACGGTC~CACAGGGGG~ACACTGAC~ACCTCCAGG~GCC 1914 
$ R Q A R Q S R R S T Q G V T L T D L Q E A  638 
C ,A~GAC~TA~GCCGTTCTACGAG~CCAGAG~C~GAAAACG~GAA~G 1975 
E K T I G R S R S T R T R E Q E N E E K  658 
Fig. 1. Nucleotide and predicted amino acid sequences of the cloned rat 
kidney M110 subunit. 
subsequent 9 amino acids. The truncations in the clone appear 
to be due to the insert size of  the cDNA library which was 
estimated < 2.2 kb. At the nucleotide level, the cloned cDNA 
is 94% homologous with rat aorta M110 [8] and 84% homolo- 
gous with the two chicken clones [7,8]. Significant nucleotide 
sequence divergence is confined to a single region, between bp 
1622 and 1790 when compared with rat aorta M, and in two 
distinct regions, bp 1114-1154 and bp 1528-1790, when com- 
pared with chicken M. Comparison at the amino acid level, 
reveals the encoded protein to be 91% homologous to the N 
terminal domain of  the rat aorta sequence and 90% homolo- 
gous to the N terminal domain of  chicken M subunit. Impor- 
tantly, the potential phosphorylation sites [7] for the cyclic 
AMP-dependent protein kinase and protein kinase C are con- 
served. 
Consistent with the single region of  divergence at the nucle- 
otide level, when the cloned rat kidney M110 is aligned with the 
amino acid sequence of rat aorta M subunit, a distinct region 
of  divergence occurs between residues 542 597 (Fig. 2A). When 
aligned with the two chicken M subunit sequences, two distinct 
divergent regions occur at residues 364-393 and 537-597. Res- 
idues 364-393, are however, completely conserved in the rat 
aorta sequence. Interestingly, part of  the amino acid sequence 
(RSXSFGRRQDDLXSXXVPSTXSTXT)  present in the rat 
kidney Ml l0  insert is also present in the two chicken MI I0  
cDNAs  (residues 552-576, chicken M) isolated by Shimizu et 
al. [7] (Fig. 2B). Notably, as discussed earlier, this region is 
absent in the rat aorta sequence [8]. The functional significance 
of the inserts in all the M isoforms cloned thus far is not clear, 
C. eLM. Haystead et al./FEBS Letters 377 (1995) 123 127 125 
A. Rat kidney insert compared with rat aorta. 
542 598 
Kidney SCSFGRRQDDLISC SVPSTTSTPTVTSPAGLQKS FLS STSTTAKTPPG S S PAGTQSR 
S S +D S + T+ + + SST+ T G+ + ++ R 
Aorta STSNRLWA EDSTEKEKDSAPTAATILVAPT VVSAAASSTTALTTTTAGTLSST S EVR 
552 608 
B. Rat kidney insert compared with chicken gizzard. 
537 597 
Rat STYHRSCSFGRRQDDLISCSVPSTTSTPTVTSPAGLQKSFLSSTSTTAKTPPGSSPAGTQS 
++Y RS SFGRRQDDL+S +VPST S T T ++ ++T+T + T S+ + S 
ChickenTS YQR SG SFGRRQDD LVS SNVPSTA STVTS S AGLQ KTLPA S ANTTTKSTTG STSA G VQS SS 
548 608 
Fi ;. 2. Amino acid sequences of the insert region of rat kidney M 110 compared with the insert regions of rat aorta and chicken gizzard M 110. Amino 
ac d sequence alignment was performed by Gene Bank BLAST analysis software [18]. Common sequences are indicated with single amino acid letter 
ce te, + indicates conservative substitutions. 
si~ce none of them appear to have significant homology with 
otler proteins in the data base. One possibility isthat the inserts 
mty target he subunit for selective interaction with other mol- 
ec ales, such as different isoforms (smooth and non-muscle) of
m ~osins. Notably, 42% of the kidney insert is made up of serine 
(2 5%) or threonine (17%) residues, suggesting the insert may be 
th: target for multiple phosphorylation events. Indeed, number 
o1 consensus phosphorylation sites are present in the insert sites 
in all the clones and include those for MAPK and protein 
kimse C. Importantly, the overall degree of conservation i  the 
N terminal domains of the M110 cDNA clones suggests that 
]VI 110 isoforms arise as the result of alternate splicing of a single 
g~ne. 
3. !. Characterization of the expressed cDNA 
In order to further characterize the role of the M110 subunit 
in the regulation of smooth muscle contraction the cloned rat 
kidney cDNA was expressed as a soluble GST-fusion protein 
in E. coli (Fig. 3). Following purification from the induced 
E coli, approximately 2-3 mg of purified fusion protein was 
ol,tained per litre of culture. On SDS-PAGE, the purified GST- 
pl otein migrated with a putative molecular weight of ~ 101 kDa, 
c(nsistent with an encoded M subunit sequence o f -73  kDa 
c(,mbined with 28 kDa fusion protein. Western blotting analy- 
s i  with a monoclonal antibody to the 58 kDa fragment of 
ct, icken gizzard M subunit, confirmed the identity of the ex- 
p] essed protein as M subunit (Fig. 3B). To test whether the 
ex pressed protein was functional, the ability of the protein to 
biad and alter the specificity of PP-1C towards 32p-labeled 
A B 
101 kDa - - - I~  / / 
F~ g. 3. Characterization f the purified GST-fusion M subunit by SDS- 
PAGE and Western blotting. (A) Coomassie blue staining of the GST- 
fusion protein following purification from GST-Sepharose and anion- 
exchange chromatography. (B) The purified GST-fusion protein was 
immunoblotted with monoclonal ntibody (gift from D. Hartshorne, 
U Arizona, Tucson) raised to the 58 kDa fragment of chicken gizzard 
Mll0. 
myosin and 32p-labeled phosphorylase a was measured in gel 
filtration studies (Fig 4). Fig. 4, shows that in the absence of 
the recombinant M subunit, PP-1C elutes from the gel filtration 
column with a putative molecular weight of-37 kDa. As a free 
catalytic subunit, PP-1C displayed low activity towards myosin 
relative to phosphorylase a. In contrast, when PP-1C was incu- 
bated with a 2 fold molar excess of recombinant M subunit 
prior to gel filtration, >90% of the phosphorylase phosphatase 
activity eluting at 37 kDa was lost. A new peak, displaying high 
myosin phosphatase activity and low phosphorylase phosphat- 
ase activity was recovered eluting at ~ 150 kDa (Fig. 4A). The 
recombinant protein interacted specifically with PP-I C, since 
A. Myosin as  the substrate .  
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Fig. 4. Analysis of the interaction ofGST-fusion M subunit with PP- 1C 
by gel filtration chromatography. Purified pig bladder PP-1C (0.3 pM) 
was incubated for 30 min on ice in the presence ( ) or absence (0) of 
recombinant M subunit (0.6 pM). The proteins were applied (100 pl) 
to an SW300 column equilibrated (1.0/min) in buffer A containing 150 
mM NaCI. Column fractions (0.2 ml) were assayed either with 32p_ 
labeled myosin (A) or 32p-labeled phosphorylase a (B). Methods for 
phosphatase assays are described [6]. 
126 C.M.M. Haystead et al./FEBS Letters 377 (1995) 123-127 
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Fig. 5. Effects of GST-fusion M subunit on the ability of PP-1C to relax microcystin treated permeabilized rabbit portal vein. (A) Spontaneous rate 
of relaxation, (B) Effects of PP-1C alone, (C) effects of GST-fusion M subunit, (D) effects of the addition of PP-1C in the presence of GST-fusion 
M subunit. Methods for the preparation and treatment of permeabilized smooth muscle are detailed elsewhere [6]. Gh EGTA 1 mM containing 
solution, t,12 = half time of relaxatiom Results shown are mean (+S.E.) of five separate experiments. 
no increase in molecular weight or effect on myosin and 
phosphorylase phosphatase activity was observed when the gel 
filtration experiments were repeated with purified PP-2AC 
(data not shown). These results suggest hat the recombinant, 
like the native protein [5,6], is capable of both selectively bind- 
ing PP-1C and altering its specificity towards myosin. Since the 
recombinant protein lacks the M21 sequence, the present result 
also indicates that the M21 subunit is not required for binding 
PP-1C to or conferring specificity for myosin. 
3.3. The effects of the recombinant protein on smooth muscle 
contraction 
To further examine the role of the M110 subunit and the 
functional properties of the recombined protein in regulating 
smooth muscle contraction, we determined its effects on relax- 
ation of microcystin-treated permeabilized smooth muscle in 
the presence and absence of purified PP-1C (Fig. 5). As shown 
previously [6,10], microcystin caused a sustained Ca2+-inde - 
pendent contraction that reached a plateau within 20 minutes 
(Fig. 5A). Following removal of the unbound microcystin, the 
contractile response was sustained for 10-15 min and then 
spontaneously relaxed slowly and incompletely. Addition of the 
recombinant protein (1.0 ~tM) to the microcystin treated mus- 
cles in the absence of PP-1C, caused no significant change in 
the rate of relaxation from control values (Fig. 5C, Table 1). 
Purified PP-1C (0.3/zM) caused a significant increase in the rate 
of relaxation (Fig. 5B) that was further accelerated when puri- 
fied PP-1C was added in combination with recombinant M110 
(Fig. 5D). These data are consistent with the gel filtration stud- 
ies (Fig. 3), showing that recombinant M l l0  was capable of 
enhancing the ability of PP-IC to selectively dephosphorylate 
32p-labeled myosin. The half time of relaxation achieved with 
the combination of recombinant M 110 (1.0/.tM) and PP-1C (0.3 
/~M) compares well with previous studies [6] using a similar 
concentration of native SMPP-1M or native 130 kDa/20 kDa 
(PP-1C + fusion protein tl/2 = 480+19 s (n = 5 ± S.E.M.) this 
study; native pig bladder SMPP-IM t,/2 = 395 + 40 s (n = 5 + 
S.E.M.) previous work; 130 kDa/20 kDa M subunit + PP-1C 
t~/2 = 427 + 24 s (n = 2, ± S.E.M.) previous work). 
4. Discussion 
In this study we have cloned a rat kidney cDNA that encodes 
a 72.5 kDa N-terminal fragment of a third isoforrn of the M110 
subunit of phosphatase 1. The encoded cDNA was expressed 
as a soluble GST-fusion protein in E. coli and its ability to 
C ~,4.M. Haystead et aLIFEBS Letters 377 (1995) 123 127 127 
interact with native PP-1C measured both in vitro and in per- 
mcabilized smooth muscle. In vitro, the fusion protein was 
capable of selectively binding PP-1C and altering the substrate 
specificity of the phosphatase towards myosin. In permeabil- 
ized smooth muscle pretreated with microcystin, the recombi- 
nant protein (1 /~M) alone did not cause relaxation, but did 
significantly enhance the ability of PP-1C to relax the muscle. 
These findings demonstrate hat the N-terminal domain of the 
M 10 subunit is the primary site of both PP-IC and myosin 
bil,ding, and therefore, determines myosin specificity. Indeed, 
tht 58 kDa fragment of M110 binds the catalytic subunit, and 
thl~ complex, in turn, binds to myosin, albeit with reduced 
eft~ciency compared to the holocomplex [7]. The M21 subunit 
is lot required for any of these functions, since this sequence 
was absent in the recombinant protein. 
['he finding that rat kidney M subunit contains an insert 
re~,ion that is completely distinct from other previously cloned 
ral (aortic) protein suggests that the activity of isoforms of M 
m~:y be regulated selectively. The function and nature of this 
re~:ulation is not clear, although, given its size (~53 amino acids 
compared with rat aorta) the insert may form a selective site 
fo~ interaction with other proteins or factors. The presence of 
thc M110 subunit(s) in many tissues [7] in addition to smooth 
mt~scle and the multiple forms of non-muscle myosins regulated 
by phosphorylation! dephosphorylation, suggests a general reg- 
ul~tory mechanism based on modulation of myosin phosphat- 
ast activity [4]. Evidence of regulated SMPP-IM activity has 
already been obtained in smooth muscles in which GTPyS and 
G-i)rotein-coupled agonists can induce an increase in MLC20 
of myosin and, consequently, force at constant Ca 2+ [11 13]. 
The increase in MLC20 phosphorylation is due to inhibition of 
SMPP-IM activity [14]. Two potential mechanisms of such 
intfibition have already been described: arachidonic acid, re- 
lea~ed by GTP~'S and Ca 2+ sensitizing agonists [15] dissociates 
th~ SMPP-IM holoenzyme and selectively inhibits its activity 
toward myosin [10,15]. This suggests a regulatory mechanism 
analogous to that proposed for regulation of glycogen synthase 
ph,~sphorylation through association/dissociation between the 
targeting G subunit and the catalytic subunit [16]. A second 
mechanism of inhibition is suggested by the correlation be- 
tw,~en thiophosphorylation of the M subunit and inhibition of 
light chain dephosphorylation n vivo [17]. Either or both of the 
ab,~ve mechanisms represent potential pathways of regulation, 
pm haps selectively modulated by M subunit isoforms (present 
stuty) within the same species. 
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